What is a contraindication for HLA viscosupplementation?

Viscosupplementation using hyaluronic acid (HA) is a treatment option primarily for osteoarthritis, particularly in the knee joint. There are specific conditions that act as contraindications for such treatments to ensure patient safety and treatment efficacy.

Pregnancy or nursing is considered a contraindication for HLA viscosupplementation because the effects of the hyaluronic acid on a developing fetus or nursing infant have not been sufficiently studied. Therefore, the potential risks that might arise from the treatment during these periods prompt healthcare professionals to avoid this treatment to ensure the safety of both the mother and the child.

Other conditions like asthma, age over 65, and cardiac disease typically do not pose a direct contraindication for HLA viscosupplementation; rather, they may need to be evaluated on a case-by-case basis depending on the patient's overall health and the presence of other factors. However, pregnant or nursing individuals face specific anatomical and physiological changes that warrant more caution in employing such treatments, making it a clear contraindication.